Jan 29 |
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
|
Jan 11 |
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
|
Dec 19 |
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Dec 19 |
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook
|
Dec 18 |
Checkpoint stock plunges 50% on FDA rejection of skin cancer drug
|
Dec 18 |
UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy
|
Dec 18 |
U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer
|
Dec 11 |
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
|
Dec 5 |
Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance
|